Why is Alembic Pharma share falling?
Having withdrawn its FY22 earnings guidance and also heightened concerns about sales in the US, going ahead, has led to shares falling over 10% in two trading sessions.
Is Alembic Pharma a good company?
Good company to work with. Recognise and Reward in timely basis. Canteen facility is also good. Good colleagues support. Provide good facility.
What is the share price of Olympic Pharma?
NSE 777.15 +32.45 ( 4.36 %)
| OPEN | 743.35 |
|---|---|
| VOLUME | 22169 |
| 52-WEEK HIGH | 1150.00 |
| 52-WEEK LOW | 720.80 |
| MARKET CAP | 15278.81 |
Who is owner of Alembic Pharma?
Alembic Group
| Traded as | BSE: 506235 NSE: ALEMBICLTD |
|---|---|
| Founder | Prof. T. K. Gajjar Prof. A. S. Kotibhasker B. D. Amin |
| Headquarters | Vadodara, Gujarat, India |
| Area served | Worldwide |
| Key people | Chirayu Amin (Chairman) Malika C. Amin (MD) Udit Amin (Director) |
Is it good to invest in alembic?
Alembic Pharma (APL) which trades at Rs 965 is an excellent company and it is a 100 year old company. Q3 FY21 results were extremely strong and the fundamentals of the company are extremely good, operating profit margin was 23%, Return on Equity was 25% and CAGR of profit for past 3 years is 25%.
What does Alembic Pharma do?
Alembic Pharmaceuticals Ltd. is involved in manufacture of pharmaceutical products, pharmaceutical substances and intermediates. It is also termed to be a market leader in macrolides segment of anti-infective drugs in India.
What is the rank of Alembic Pharma in India?
Top 25 pharmaceutical Companies by Net Sales
| S.NO | Company Name | Net Sales (Rs. cr) |
|---|---|---|
| 11. | Ipca Labs | 4.36 Thousand Crore Rupees Approx. |
| 12. | Alembic Pharma | 4.13 Thousand Crore Rupees Approx. |
| 13. | Abbott India | 4 Thousand Crore Rupees Approx. |
| 14. | GlaxoSmithKline | 3.22 Thousand Crore Rupees Approx. |
How many divisions are in Alembic Pharmaceuticals?
7 divisions
Out of Alembic’s 7 divisions, 4 of them have witnessed a core structural change within the last two years.
Can I buy Alembic Pharma?
Yes Securities has buy call on Alembic Pharmaceuticals with a target price of Rs 820. The current market price of Alembic Pharmaceuticals is Rs 779.9. Alembic Pharmaceuticals Ltd., incorporated in the year 2010, is a Mid Cap company (having a market cap of Rs 15335.85 Crore) operating in Pharmaceuticals sector.
What does Alembic Pharma make?